Foghorn Therapeutics logo

Foghorn Therapeutics jobs and careers

Cambridge, MA, United States

About Foghorn Therapeutics

Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing them to identify, validate, and potential drug targets within the system.

Founded in 2015 by Cigall Kadoch.

Founded
2015
Employees
125
Total funding
$221M
Headquarters
Cambridge

Leadership

The top of Foghorn Therapeutics's org chart, with how many people report into each leader.

AGPhoto of Adrian Gottschalk

Adrian Gottschalk

CEO

88 reports

SBPhoto of Steven Bellon

Steven Bellon

Chief Scientific Officer

58 reports

KHPhoto of Kristian F. Humer

Kristian F. Humer

Chief Financial Officer

8 reports

ARPhoto of Anna Rivkin

Anna Rivkin

Chief Business Officer

6 reports

MLPhoto of Michael Lacascia

Michael Lacascia

Chief Legal Officer

3 reports

CCPhoto of Carlos Costa

Carlos Costa

Chief People Officer

3 reports

AQ

Alfonso Quintás-Cardama

Chief Medical Officer

2 reports

SKPhoto of Sunita Katyal

Sunita Katyal

Executive Assistant To Chief Executive Officer

KHPhoto of Karin Hellsvik

Karin Hellsvik

Vice President, Corporate Affairs & Investor Relations, Chief Of Staff To The CEO

Board

DSPhoto of David Schenkein

David Schenkein

Advisor

ISPhoto of Ian Smith

Ian Smith

Director

CSPhoto of Charles L. Sawyers

Charles L. Sawyers

Advisor

GCPhoto of Gerald Crabtree

Gerald Crabtree

Advisor

SGPhoto of Simba Gill

Simba Gill

Director

DCPhoto of Doug Cole

Doug Cole

Director

Jobs at Foghorn Therapeutics

No open positions right now. Explore more companies on TheJobsMap.